(Q50731085)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Inhibition of bortezomib-induced apoptosis by red blood cell uptake (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

L M C Wheat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

S L Kohlhaas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

J Monbaliu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

R De Coster

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A Majid

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

R J Walewska

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

22 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

1646-1649

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404290

25 December 2019

exact match

0 references

cites work

Treatment of human chronic lymphocytic leukemia cells with the proteasome inhibitor bortezomib promotes apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404290

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404290

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404290

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404290

Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404290

Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404290

21 January 2018

Identifiers

DOI

10.1038/SJ.LEU.2404290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16791268%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference